Gautam Goel, Ph.D. is Co-founder and CEO of Aetherium Bio, where he is building a next-generation computational platform that integrates deep learning with physics-based molecular dynamics to engineer multi-targeting fusion proteins for chronic inflammatory diseases. A seasoned biotech executive with over 20 years at the intersection of AI and drug discovery, Gautam previously served as Chief AI/Data Science Officer at hC Biosciences, where he shaped corporate strategy from inception and helped raise $40M in Series A funding. His career spans leadership roles across computational biology, precision medicine, and translational development, with contributions to clinical trials, functional genomics, and immunometabolism research published in Nature, Science, The Lancet, and other leading journals. Gautam has helped raise approximately $200M in venture, strategic, and non-dilutive capital across multiple organizations. He holds a Ph.D. in Bioengineering from Georgia Tech and brings deep expertise in systems immunology, ML-driven protein engineering, and strategic company building.